Loading clinical trials...
Loading clinical trials...
A Phase 2 Multicenter, Randomized, Open Label, Parallel Assignment, Pilot Study to Assess the Efficacy and Safety of Reparixin Following Islet Transplantation in Patients With Type 1 Diabetes Mellitus
Conditions
Interventions
Reparixin
Locations
2
Germany
University Hospital Carl Gustav Carus Dresden
Dresden, Germany
Ospedale San Raffaele
Milan, Italy
Start Date
July 28, 2010
Primary Completion Date
April 30, 2013
Completion Date
April 30, 2013
Last Updated
March 11, 2021
Lead Sponsor
Dompé Farmaceutici S.p.A
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions